Paul Andrew Moore

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Andrew Moore:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. Chief Scientific Officer Common Stock 48,497 $1,099,596 $22.67 12 Jan 2026 Direct
Zymeworks Inc. Chief Scientific Officer Restricted Stock Unit 47,000 $790,977 $14.92 12 Jan 2026 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 200,000 18 Jul 2022 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 70,000 12 Jan 2026 Direct
Zymeworks Inc. Chief Scientific Officer Performance Stock Unit 66,000 12 Jan 2026 Direct

Insider Reports Filed by Paul Andrew Moore

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 12 Jan 2026 6 -$216,759 4 Chief Scientific Officer 12 Jan 2026, 20:32
ZYME Zymeworks Inc. 05 Jan 2026 6 -$504,699 4 Chief Scientific Officer 05 Jan 2026, 20:18
ZYME Zymeworks Inc. 10 Jan 2025 2 $0 4 Chief Scientific Officer 10 Jan 2025, 18:07
ZYME Zymeworks Inc. 06 Jan 2025 6 -$316,391 4 Chief Scientific Officer 06 Jan 2025, 20:35
ZYME Zymeworks Inc. 05 Jan 2024 6 -$105,699 4 Chief Scientific Officer 08 Jan 2024, 18:01
ZYME Zymeworks Inc. 05 Jan 2023 2 $0 4 Chief Scientific Officer 06 Jan 2023, 19:00
/report/000089924322026386-moore-paul-andrew-2022-07-18 Zymeworks Inc. 18 Jul 2022 1 $0 4 Chief Scientific Officer 19 Jul 2022, 21:05
/report/000089924322026385-moore-paul-andrew-2022-07-18 Zymeworks Inc. 18 Jul 2022 0 $0 3 Chief Scientific Officer 19 Jul 2022, 21:00